2 ASX shares to buy for a post-pandemic world

Here's why I would buy these ASX shares, including CSL Limited (ASX: CSL), for a post-pandemic ASX world.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The coronavirus pandemic has turned the world of investing (as well as most other worlds) upside down. Although the S&P/ASX 200 Index (ASX: XJO) and the broader markets have substantially recovered from the lows we saw in March, it's still a difficult landscape in which to choose ASX shares for one's own portfolio.

We still don't know exactly which companies will be affected by the coronavirus shutdowns, how long they will be affected for and how long it will take for things to return to 'normal'.

Despite my belief that a strong recovery will eventually come, I think it's fairly safe to say that the economy won't look quite the same as it did before the pandemic struck.

So here are 2 ASX shares that I think will make great investments in a post-pandemic world:

CSL Limited (ASX: CSL)

CSL is the largest company on the ASX – and for good reason. It has grown at such a rate that its shares have more than tripled in value over the past 5 years. CSL is a leader in the global blood medicine and vaccination fields. CSL has been called upon before by the Australian government to manufacture large batches of vaccines when Swine Flu was emerging as a threat a few years ago – and its services might be required again if a vaccine for COVID-19 is found.

In fact, just today it was announced that CSL is working on an immunoglobulin therapy that has the potential to help individuals who have contracted the disease. All in all, I think CSL is a winning company – rain, hail or shine.

Ramsay Health Care Limited (ASX: RHC)

Ramsay is the largest operator of private hospitals in Australia and also has a significant global presence with its operations in the UK, Indonesia and France.

This company hasn't escaped unscathed from the coronavirus crisis – suffering when the government banned all non-essential elective surgeries in preparation for the pandemic. As a result, it initiated a capital raising and suspended its dividend payments – ending a 20-year streak for the latter.

Still, I think this company has a bright post-pandemic future. As long as the coronavirus is still around, Ramsay will be playing an important role in treatment. And once we enter a post-pandemic world, the ageing demographics of our population give Ramsay a strong tailwind and should ensure its top-notch hospitals remain in strong demand for decades to come.

Sebastian Bowen owns shares of Ramsay Health Care Limited. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. The Motley Fool Australia has recommended Ramsay Health Care Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Shot of a young scientist using a digital tablet while working in a lab.
Healthcare Shares

Which ASX biotech shares are pioneering the future of medicine?

Uncover the risks and rewards of high-stakes investments in ASX biotech stocks.

Read more »

a woman holds a facebook like thumbs up sign high above her head. She has a very happy smile on her face.
Healthcare Shares

Buy this cheap small cap ASX share for a very big return

Bell Potter thinks investors should be snapping up this small cap while it is cheap.

Read more »

A young woman holds her hand to her mouth in surprise as she reads something on her laptop.
Healthcare Shares

This ASX 200 stock can rocket to a record high: Broker

This high-flying stock is far from having its wings clipped.

Read more »

Shot of a young scientist using a digital tablet while working in a lab.
Share Gainers

Guess which ASX 200 healthcare share just rocketed 11% on 'groundbreaking trial'

Up 67% in a year, investors are sending the ASX 200 healthcare share soaring again today.

Read more »

pause in medical asx share price represented by doctor holding hand up in stop motion
Healthcare Shares

ASX 200 healthcare stock up 40% in 6 months halted ahead of major trial results

Neuren Pharmaceuticals will reveal Phase 2 clinical results for its second drug candidate shortly.

Read more »

Shot of a young scientist using a digital tablet while working in a lab.
Healthcare Shares

Can CSL shares deliver market-beating returns for investors?

Is this a good place to invest your hard-earned money? Let's find out.

Read more »

A man in a business suit whose face isn't shown hands over two australian hundred dollar notes from a pile of notes in his other hand to an outstretched hand of another person.
Healthcare Shares

Guess which ASX All Ords insider just bought 50 million shares in their company

Some major insider buying has taken place. What does this mean?

Read more »

Man with a sleep apnoea mask on whilst sleeping.
Broker Notes

ResMed shares higher as company 'turns the GLP threat into an opportunity': Fundie

ResMed is having a great run in 2024 with the share price up 29% already.

Read more »